Skip to content

Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer

Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer: A Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03209076
Acronym
RAR
Enrollment
120
Registered
2017-07-06
Start date
2018-02-01
Completion date
2020-12-01
Last updated
2019-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Neoplasms, Sexual Dysfunction, Urinary Incontinence, Quality of Life

Keywords

rectal neoplasms, sexual dysfunctions, Urinary incontinence, Quality of life, robotic surgical procedures, laparoscopy

Brief summary

Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer. Primary endpoint: Compare urinary dysfunction between robotic and laparoscopic approach.

Detailed description

Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer. The Aim of the study is to compare two surgical approaches (robotic versus laparoscopic) for rectal cancer treatment regarding functional outcomes (sexual and urinary dysfunctions), quality of life, post operative outcomes and oncologic outcomes. Patients with the diagnosis of T3 mid and low rectal cancer will be randomized to robotic or laparoscopic procedure after neoadjuvant chemoradiation. Quality of life questionnaires and Urodynamic test will be applied before and after the surgical procedures.

Interventions

PROCEDURERobotic

Robotic low anterior resection

PROCEDURELaparoscopic

Laparoscopic low anterior resection

Sponsors

Hospital de Câncer de Barretos
CollaboratorOTHER
Hospital dos Servidores do Estado do Rio de Janeiro
CollaboratorOTHER_GOV
Instituto Nacional de Cancer, Brazil
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective randomized trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Mid or low Rectal Adenocarcinoma * Performance Status (ECOG) 0 - 2

Exclusion criteria

* Metastatic disease * Congestive heart failure * Renal failure * Diabetes * Pregnancy * Neurologic disorders * Alfa blockers user * Patients who are candidates to APR ( Abdomino-perineal resection)

Design outcomes

Primary

MeasureTime frameDescription
Urinary dysfunctionChange from Before surgery to 3 months after surgeryUrodynamic test

Secondary

MeasureTime frameDescription
Sexual dysfunctionChange from Before surgery to 3 months after surgeryQuality of life questionnaire
Post operative outcomesWithin the first 30 days after the surgical procedurePost operative complications
CostsFrom the surgical procedure until the last follow up, which will be 24 months or the day of death.Costs in Brazilian currency of each procedure

Countries

Brazil

Contacts

Primary ContactMarcus Valadão, Dr
drmarcusvaladao@gmail.com55 21 32071161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026